AstraZeneca PLC
11978,00
22-августа-25 08:29:58
15 мин. задержка
Акции
-74,00
-0,61%
Сегодняшний диапазон
11940,00 - 12126,00
ISIN
N/A
Источник
Cboe
- Котировки
- Графики
Новости
- Статистика
-
SOPHiA Genetics, AstraZeneca Team Up To Expand Liquid Biopsy Testing To 20 New Locations Globally
10 сен 2024 08:30:45 Источник NASDAQ US Markets
-
AstraZeneca :Dato-DXd Fails To Significantly Improve Overall Survival In Phase III Lung Cancer Trial
09 сен 2024 18:50:46 Источник NASDAQ US Markets
-
Chinese Authorities Detain AstraZeneca Employees
05 сен 2024 14:39:29 Источник NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
03 сен 2024 00:15:42 Источник NetDania Notify
-
QIAGEN and AstraZeneca Expand Pact to Develop CDx in Chronic Diseases
30 авг 2024 06:35:45 Источник NASDAQ Stocks
-
NetDania - New 12 months High: AstraZeneca PLC
30 авг 2024 03:41:41 Источник NetDania Notify
-
Interesting AZN Put And Call Options For November 15th
23 авг 2024 08:14:24 Источник NASDAQ Stocks
-
AZN: Enhertu Gets US Breakthrough Therapy Designation For HER2 Low/Ultralow Metastatic Breast Cancer
19 авг 2024 00:08:28 Источник NASDAQ US Markets
-
AstraZeneca's Imfinzi Gets US Approval For Resectable Early-stage Lung Cancer
16 авг 2024 00:28:46 Источник NASDAQ US Markets
-
AstraZeneca (AZN) Imfinzi Combo Gets EU Nod for Uterine Cancer
15 авг 2024 04:38:12 Источник NASDAQ Stocks
-
Ex-Dividend Reminder: Cencora, AstraZeneca and Wells Fargo
07 авг 2024 07:27:01 Источник NASDAQ Stocks
-
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
04 авг 2024 07:42:17 Источник NASDAQ US Markets
-
AstraZeneca: Calquence Combo Enhances PFS In First-Line CLL In Phase III Trial
29 июл 2024 00:38:02 Источник NASDAQ US Markets
-
AstraZeneca Reports ODAC's Review Of Imfinzi - Quick Facts
26 июл 2024 00:05:05 Источник NASDAQ US Markets
-
AstraZeneca Q2 Profit Rises, Lifts FY24 Outlook
24 июл 2024 23:51:34 Источник NASDAQ US Markets
-
Interesting AZN Put And Call Options For August 23rd
03 июл 2024 10:16:51 Источник NASDAQ US Markets
-
AstraZeneca: CHMP Recommends Lynparza And Imfinzi Combination For EU Approval In Endometrial Cancer
01 июл 2024 00:09:21 Источник NASDAQ US Markets
-
Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
28 июн 2024 07:33:02 Источник NASDAQ Stocks
-
AstraZeneca: Imfinzi Trial Fails To Meet Endpoint In Early-stage Non-small Cell Lung Cancer
25 июн 2024 00:08:02 Источник NASDAQ US Markets
-
AstraZeneca: Phase III Truqap Trial Plus Chemotherapy Fails To Meet Primary Goals In Breast Cancer
18 июн 2024 00:15:21 Источник NASDAQ US Markets